P-selectin (CD62P) is expressed on activated platelets and on stimulated endothelial cells. It interacts with P-selectin glycoprotein ligand-1 (PSGL-1; CD162) for adhesion of activated platelets on leukocytes and for rolling of leukocytes on stimulated endothelial cells. Recently, resting and activated platelets have been shown to roll on endothelial P-selectin, indicating that platelets express (a) ligand(s) for P-selectin. Here we show that P-selectin specifically precipitated one 28-kDa glycoprotein from the whole cell lysates and the membrane lysates of human platelets in a Ca 2+ -dependent manner. Further, the purified 28-kDa molecule could inhibit the binding of P-selectin to human resting and activated platelets. In contrast, KPL1 (a leukocyte adhesion blocking MoAb to PSGL-1) did not neutralize the binding of P-selectin to human platelets, even though it abolished the binding of P-selectin to human promyeloid HL-60 cells. Our results thus indicate that the 28-kDa glycoprotein may function as an important platelet ligand for P-selectin.
Introduction
The interactions of platelets, leukocytes and vascular endothelial cells are critical for physiological processes, such as clotting and host defense, and for pathological processes, such as thrombosis and inflammation. For example, upon vascular injury, platelets are quickly recruited to the damaged vessels at the site of injury, where they form platelet aggregates and blood clotting to prevent excessive bleeding or to occlude atherosclerotically obstructive arteries. Following tissue infection and injury, leukocytes can roll on and adhere to the activated endothelial cells, and then, transmigrate through the vessels to fight against various pathogens or cause further damage of the injured tissues and organs.
P-selectin (CD62P) is a member of the selectin family of cell adhesion molecules. It is normally stored in the ␣-granules of platelets and the Weibel-Palade bodies of endothelial cells. Upon thrombogenic and inflammatory challenges, P-selectin is rapidly expressed, by exocytosis, on the cell surfaces of activated platelets and stimulated endothelial cells. The cell surface P-selectin binds to a disulfide bondlinked homodimeric sialomucin, called P-selectin glycoprotein ligand-1 (PSGL-1; CD162). PSGL-1 is expressed on the cell surface of most leukocytes, such as neutrophils, monocytes, certain subsets of T lymphocytes including Th1 cells, eosinophils and basophils. P-selectin interacts with PSGL-1 to mediate heterotypic aggregation of the activated platelets on leukocytes and rolling of leukocytes on the stimulated endothelial cells (1) (2) (3) (4) (5) . P-selectin knockout mice are defective in leukocyte rolling, extravasation, and haemostasis (6, 7) and PSGL-1 knockout mice manifest impaired rolling and migration of leukocytes (8) , attesting to the functional importance of this receptor/ligand pair of cell adhesion molecules.
Resting and activated platelets have been shown to roll on endothelial P-selectin in vivo, indicating a ligand activity for P-selectin on platelets (9, 10) . Recently, P-selectin was shown to react with platelet glycoprotein Ib␣ in platelet glycoprotein Ib-IX-V complex (11) . Further, human platelets were shown to express PSGL-1, which appeared to mediate platelet binding to the stimulated endothelial cells in vivo (12) . Along these lines of investigation, we searched for the potential P-selectin ligand(s) on human platelets. Using P-selectin affinity chromatography, we identified a 28-kDa glycoprotein from human platelets as a P-selectin specific binding protein. We then examined the biological importance of this newly discovered molecule for the binding of P-selectin to human platelets.
Materials and Methods
Proteins and antibodies. P-and E-selectin receptor-globulins (P-and Eselectin Rg) were prepared as described previously (13, 14) . P-selectin Rg was constructed by fusing the lectin domain, the epidermal growth factor-like domain and the first two complement protein-like repeats of P-selectin with the Fc portion of human IgG 1 . E-selectin Rg was constructed by fusing the lectin domain, the epidermal growth factor-like domain and the all six complement protein-like repeats of E-selectin with the Fc portion of human IgG 1 .
A leukocyte adhesion blocking IgG 1 monoclonal antibody (MoAb) to Pselectin, G1, and a leukocyte adhesion non-blocking IgG 1 MoAb to P-selectin, PS1, were prepared and characterized as described previously (13, 15, 16) . F(ab) 2 fragments of G1 and PS1 MoAbs were prepared using ImmunoPure ® F(ab) 2 100 units/ml penicillin and 100 g/ml streptomycin at 37°C in the presence of 5% CO 2 .
P-selectin affinity chromatography. Out-dated human platelets, supplied by Shanghai Blood Center, were extensively washed with PBS containing 10 mM EDTA and frozen at -70°C until use. Frozen platelets were lysed in a Ca 2+ -containing buffer and the P-selectin binding proteins were isolated by P-selectin affinity chromatography exactly as previously described (13) (14) (15) . The EDTA eluted molecules were re-calcified by adding 1 M CaCl 2 to the final concentration of 20 mM CaCl 2 and the eluates were then loaded on a P-selectin Rg affinity column (10 mg P-selectin Rg bound to ~5 ml beads of Protein A Sepharose 4 Fast Flow; Amersham Pharmacia Biotech, Shanghai, China). After washing with 50 ml of the calcium-containing buffer, the bound proteins were eluted with the same buffer containing 10 mM EDTA. The eluted fractions were pooled and dialyzed against 20 mM Tris-H 3 PO 4 , pH 6.3, 0.01% Brij-35 and 0.02% NaN 3 (Buffer A) at 4°C overnight. The dialyzed samples were concentrated on a Mono-Q PC 1.6/5 ion-exchange column™ (Smart System ® ; Amersham Pharmacia Biotech) by a step-elution with Buffer A containing 1 M NaCl. The final protein was dialyzed into PBS containing 0.01% Brij-35. It was aliquoted and frozen at -70°C until use.
Iodination of platelet protein. The platelet protein, isolated by P-selectin affinity chromatography as described above, was iodinated with 0.5 mCi of carrier free Na 125 I (Amersham Pharmacia Biotech) using IODO-BEADS (Pierce). Free 125 I was removed by gel filtration through a Sephadex G-25 column equilibrated with PBS, 0.01% Brij-35 and 0.02% NaN 3 . The protein peak was collected and stored in the presence of 1% BSA at 4°C.
P-selectin affinity precipitation assay. Aliquots of 5% Protein A-Sepharose CL-4B beads (100 l/aliquot; Amersham Pharmacia Biotech) were incubated with 30 g human IgG, P-or E-selectin Rg at 22°C for 1 h (14) . After washing three times with PBS, they were incubated with the 125 I-labeled platelet protein (500,000 cpm/tube) in 0.4 ml PBS containing 1 mM CaCl 2 , 1 mM MgCl 2 , 0.1% Brij-35 and 0.02% NaN 3 at 22°C for 2 h with end-to-end rotation. After incubation, the beads were washed five times with the same buffer and then transferred to new Eppendorf tubes. Samples were supplemented with SDS sample buffer in the presence of 5% ␤-mercaptoethanol, boiled for 5 min, and subjected to 7-15% gradient SDS-PAGE followed by autoradiography. For EDTA control experiments, calcium-and magnesium-free PBS in the presence of 10 mM EDTA was used throughout the entire assay. For antibody inhibition experiments, the P-selectin Rg bound beads were incubated with 30 g of G1 F(ab) 2 or PS1 F(ab) 2 at 22°C for 30 min, prior to addition of the 125 I-labeled platelet protein.
Protease and glycosidase digestion. Digestion with recombinant peptide: N-glycosidase F and H (PNGase F and H; both at 40 units/ml; Boehringer Mannheim, Indianapolis, IN), heparinases I, II and III (Sigma, Shanghai, China), O-sialoglycoprotein endopeptidase (OSGE; Accurate Chemical Co., Westbury, NY), pronase ® (Boehringer Mannheim), pepsin, mercuripapain, trypsin-TPCK (N-tosyl-L -phenylalanine chloromethyl ketone) and elastase (Worthington Biochemical Corporation, Lakewood, NJ; all at 0.1 mg/ml) was carried out in PBS, pH 7.4. Digestion with O-glycosidase™ (0.1 unit/ml; Boehringer Mannheim) and Newcastle disease virus sialidase (2 units/ml; Oxford GlycoSystems, Inc. Oxford, UK) was performed in 0.1 M sodium acetate, pH 5.5. The total volumes of each reactant were 50 l and the samples were incubated at 37°C for 1 h (for protease digestion) or for 24 h (for glycosidase digestion). To prevent proteolysis by potential contaminants, all glycosidase digestion was carried out in the presence of 20 M leupeptine, 20 M antipain, 20 M pepstatin, 1 mM benzamidine and 0.02% NaN 3 (all protease inhibitors were purchased from Sigma).
Surface biotinylation, P-selectin precipitation and streptavidin detection. Freshly isolated platelets were purchased from Shanghai Blood Center. Platelets (~5 ϫ 10 8 ) were biotinylated with 1 mg sulfo-N-hydroxysulfosuccinimide-LC biotin (Pierce) and the surface biotinylated platelets were lysed as described (12) . Each aliquot (~1 ϫ 10 8 platelets) of platelet lysates was incubated with 100 l Protein A-Sepharose CL-4B beads without or with preincubation with 30 g of human IgG, E-selectin Rg or P-selectin Rg at 22°C for 1 h. After incubation at 4°C overnight with end-to-end rotation, these beads were washed five times with 50 mM Tris-HCl, pH 8.3, 400 mM NaCl, 0.05% Triton X-100, 1 mM CaCl 2 , 1 mM MgCl 2 . Following washing, they were transferred to new Eppendorf tubes. Samples were treated with SDS sample buffer in the presence of 5% ␤-mercaptoethanol, boiled for 5 min, and subjected to 7-15% gradient SDS-PAGE. After electrophoresis, the separated proteins were transferred to blotting membranes and detected by horseradish peroxidase-conjugated streptavidin followed by a chemiluminescent detection system (15) .
Platelet preparation. Human fresh bloods from healthy volunteers were mixed immediately with acid-citrate-dextrose (ACD; 38 mM citric acid, 75 mM trisodium citrate and 100 mM dextrose; 10% ACD final concentration). Platelet-rich plasma (PRP) was obtained by centrifugation at 150 ϫ for 10 min at 22°C. PRP was carefully aspirated using a plastic pipette. Prostaglandin E 1 (Sigma) was added to a 40-nM final concentration to obtain resting human platelets; prostaglandin E 1 was not added for activated human platelets. It was then centrifuged at 1,600 ϫ g for 10 min at 22°C. The plasma was aspirated and the platelet pellet was resuspended in PBS/BSA (phosphate buffered saline, pH 7.4, supplemented with 1% bovine serum albumin). For activated human platelets, the platelet pellets were resuspended in PBS/BSA in the presence of 0.5 unit/ml ␣-thrombin (Sigma) for 5 min. In some experiments, platelets were fixed by mixing them with an equal volume of 2% paraformaldehyde (freshly prepared in PBS) at 22°C for 1 h. The fixed resting and activated platelets were washed three times with PBS/BSA by centrifugation at 1,600 ϫ g for 5 min at 22°C. They were resuspended in PBS/BSA for immediate usage.
Flow cytometric assays. The isolated human platelets and HL-60 cells were resuspended at 1 ϫ 10 6 cells/ml in either PBS/Ca 2+ /BSA (PBS containing 1 mM CaCl 2 , 1 mM MgCl 2 and 1% BSA), or PBS/EDTA/BSA (PBS containing 10 mM EDTA and 1% BSA). Each 0.5 ml aliquot of fixed or non-fixed human platelets was incubated with 3 g human IgG (Sigma) or P-selectin Rg followed by 3 g of an affinity-purified fluorescein-5-isothiocyanate (FITC)-conjugated goat Ab to human IgG (Pierce) at 22°C for 1 h with end-to-end rotation, as described before (14, 17) . For antibody inhibition experiments, 3 g P-selectin Rg was incubated with 10 g G1 F(ab) 2 (a leukocyte adhesion blocking MoAb to P-selectin), or PS1 F(ab) 2 (a leukocyte adhesion nonblocking MoAb to P-selectin), in 50 l PBS/Ca 2+ /BSA for 30 min, prior to adding cells. Alternatively, platelets and HL-60 cells were incubated with 10 g mouse IgG 1 or KPL-1 (a leukocyte adhesion blocking MoAb to PSGL-1), in 50 l PBS/Ca 2+ /BSA for 30 min, prior to adding P-selectin Rg.
For detection of P-selectin expression, each 0.5 ml aliquot of human resting or activated platelets was incubated with 3 g mouse IgG 1 or a PS1 MoAb at 22°C for 1 h with end-to-end rotation. Following washing once, each of them was incubated with 3 g of an affinity-purified FITC-conjugated goat Ab to mouse IgG (Pierce) at 22°C for 1 h with end-to-end rotation. After washing once, platelets were spun down at 1,600 ϫ g for 5 min at 22°C. Following discarding the supernatants, each sample was resuspended in 0.5 ml of PBS/Ca 2+ /BSA or PBS/EDTA/BSA for immediate flow cytometric analysis (FACScan ® , Becton Dickinson & Co., Mountain View, CA).
Results

P-selectin Precipitates a Molecule from Human Platelets
Based on the previous reports, we thought that human platelets must constitutively express (a) P-selectin ligand(s) on their cell surfaces. We decided to identify the P-selectin binding protein(s) from human platelets using P-selectin affinity chromatography. The lysates of human platelets were loaded on a P-selectin affinity column in the presence of calcium. After extensive washing, the bound molecules were eluted from the P-selectin affinity column by EDTA. The eluted proteins were then labeled with 125 I for further analysis (Fig. 1A) . On SDS-PAGE, it had apparent molecular masses of ~28 kDa under reducing conditions and ~25 kDa under non-reducing conditions, suggesting that it might contain (an) intramolecular disulfide bond(s).
To verify the specificity of this interaction, we performed an affinity precipitation assay. Fig. 1B shows that the purified molecule could be precipitated by P-selectin Rg, but not by human IgG or E-selectin Rg.
Further, EDTA and G1 (a leukocyte adhesion blocking MoAb to Pselectin), but not PS1 (a leukocyte adhesion non-blocking MoAb to P-selectin), could inhibit the binding (Fig. 1C) . Thus, our results demonstrated the specificity of the interaction of the ~28-kDa platelet molecule with P-selectin.
The P-selectin Binding Molecule from Human Platelets Is a Glycoprotein
We then examined the accessibility of this molecule to various proteases and glycosidases. Fig. 2A shows that the 125 I-labeled platelet molecule could be completely digested by pronase ® and partially digested by trypsin-TPCK, chymotrypsin and mercuripapain, but apparently could not be digested by elastase, pepsin and OSGE. Digestion with PNGase F could lead to a shift in the electrophoretic mobility, demonstrating that it contained N-linked glycans (Fig. 2B) . Notably, the partial PNGase F digestion of the platelet molecule observed here was most likely due to the interference of protein folding as the complete digestion could be achieved by boiling of the sample in the presence of 0.05% SDS prior to the digestion (data not shown). However, digestion with Newcastle disease virus sialidase, PNGase H, O-glycosidase™, heparinases I, II and III, could not cause any detectable shifts in the electrophoretic mobility. These results indicated that the platelet molecule isolated by P-selectin affinity chromatography was indeed a glycoprotein. Fig. 1 Isolation of a P-selectin binding molecule from human platelets. A P-selectin binding molecule from human platelets was isolated by P-selectin affinity chromatography with EDTA elution and visualized by 125 I labeling. Samples were boiled in the SDS sample buffer in the presence (R) or absence (NR) of 5% ␤-mercaptoethanol for 5 min and subjected to 7-15% gradient SDS-PAGE followed by autoradiography (panel A). For specificity experiments, the 125 I-labeled P-selectin binding molecule was precipitated with the human IgG, E-and P-selectin Rg (E-or P-Rg) bound Protein A beads (panel B), or precipitated with the P-selectin Rg bound Protein A beads in the presence of Ca 2+ , EDTA, G1 F(ab) 2 (a leukocyte adhesion blocking MoAb to P-selectin) or PS1 F(ab) 2 (a leukocyte adhesion nonblocking MoAb to P-selectin; panel C) Fig. 2 Protease and glycosidase digestion of the P-selectin binding molecule. The 28-kDa molecule was digested with various proteases (panel A) and glycosidases (panel B). Samples were then boiled in the SDS sample buffer in the presence of 5% ␤-mercaptoethanol for 5 min and subjected to 7-15% gradient SDS-PAGE followed by autoradiography
The Cell Surface of Platelets Expresses 28-kDa Molecules
To determine the cellular localization of the 28-kDa glycoprotein, we carried out the experiments of cell surface biotinylation, P-selectin affinity precipitation and streptavidin blotting. It was our assumption that if the 28-kDa molecules were expressed on the cell surface of platelets, they would be biotinylated by a water-soluble biotin. Therefore, following precipitation with P-selectin, they could be detected by streptavidin. Fig. 3 shows that horseradish peroxidase-conjugated streptavidin indeed detected a 28-kDa protein band, separated on SDS-PAGE under reducing conditions, from the platelet proteins precipitated by P-selectin Rg, but not precipitated by Protein A and human IgG. Thus, our result confirmed the cell surface expression of the 28-kDa molecules on human platelets. Further, we found that this P-selectin affinity precipitation assay could not detect any other protein bands, including platelet glycoprotein Ib-IX-V complex and PSGL-1, from human platelets. Again, this finding was fully consistent with the data obtained by P-selectin affinity chromatography (Fig. 1) .
It should be pointed out that a weak 28-kDa protein band was detected from the cell surface labeled platelets following E-selectin precipitation (Fig. 3) . Given the endothelial E-selectin has been shown to mediate the rolling of the resting and activated platelets (10), our result suggested that the 28-kDa protein might function as a platelet ligand for E-selectin. Apparently, further experimentation is required to verify this finding.
The Isolated 28-kDa Protein Inhibits P-selectin Binding to Human Platelets
We used a cell surface-binding assay to measure the in vitro binding of recombinant P-selectin Rg to human platelets. In this assay, the binding events were reported by an FITC-conjugated Ab to human IgG using flow cytometry. As shown in Fig. 4 , compared to mouse IgG, PS1 (an anti-P-selectin MoAb), bound poorly to resting human platelets, but Human platelets were biotinylated with a water-soluble biotin and then lysed. The platelet lysates were precipitated with Protein A beads (sham) without or with human IgG, E-selectin Rg and P-selectin Rg. Samples were boiled in the SDS sample buffer in the presence of 5% ␤-mercaptoethanol for 5 min and subjected to 7-15% gradient SDS-PAGE followed by blotting with horseradish peroxidase-conjugated streptavidin. The binding events were visualized by a chemiluminescent detection system Fig. 4 Inhibition of P-selectin binding to resting and activated human platelets by the 28-kDa molecule. The washed resting (panel A) and activated (panel B) human platelets were incubated with mouse IgG, PS1 (a MoAb to P-selectin), human IgG or P-selectin Rg followed by an FITC-conjugated goat Ab against mouse or human IgG. For antibody inhibition experiments, P-selectin Rg was preincubated with either G1 F(ab) 2 (a leukocyte adhesion blocking MoAb to P-selectin) or PS1 F(ab) 2 (a leukocyte adhesion non-blocking MoAb to P-selectin). For EDTA chelation experiments, a calcium and magnesiumfree PBS solution supplemented with 10 mM EDTA was used throughout the entire binding assay, including all the washing and incubation steps. The binding events were analyzed from 10 4 platelets using flow cytometry bound avidly to activated human platelets. P-selectin Rg, but not human IgG, bound to both the resting and activated human platelets. The binding specificity of P-selectin Rg to human platelets was verified by antibody inhibition experiments. G1 F(ab) 2 (a leukocyte adhesion blocking MoAb to P-selectin), but not PS1 F(ab) 2 (a leukocyte adhesion non-blocking MoAb to P-selectin), inhibited the binding of P-selectin Rg to human platelets. Further, EDTA, a chelator for divalent cations, abolished the binding of P-selectin Rg to human platelets, indicating that the binding was dependent on divalent cations, presumably on Ca 2+ . Importantly, the isolated 28-kDa protein inhibited the binding of P-selectin to both the resting and activated human platelets, demonstrating the functional importance of this molecule for the binding of Pselectin to platelets. It should be mentioned that although the resting and activated human platelets used here were fixed with 2% paraformaldehyde, similar results were observed using both the non-fixed resting and activated human platelets (data not shown). Further, the 28-kDa protein did not inhibit the binding of 10E5 (a blocking MoAb to GPIIb/IIIa) to activated human platelets (data not shown).
A PSGL-1 Blocking MoAb Fails to Attenuate the Binding of P-selectin to Platelets
To investigate the functional importance of the reported platelet PSGL-1 for P-selectin recognition, we examined whether KPL1, a leukocyte adhesion blocking MoAb to PSGL-1, could neutralize the binding of P-selectin to human platelets. Fig. 5 shows that compared to human IgG, P-selectin Rg bound avidly to human promyeloid HL-60 cells and resting and activated human platelets. As expected, KPL1 (a leukocyte adhesion blocking MoAb to PSGL-1) abolished the binding of P-selectin Rg to HL-60 cells. However, it had no inhibitory effects on the binding of P-selectin Rg to both the resting and activated human platelets. This finding is consistent with the result of failure for isolation of platelet PSGL-1 by P-selectin affinity chromatography ( Fig. 1) and P-selectin affinity precipitation (Fig. 3) .
Discussion
Although the functional importance of endothelial P-selectin for mediation of leukocyte adhesion in inflammation is fully recognized (1) (2) (3) (4) (5) , little is known for the physiological and pathological roles of platelet P-selectin in haemostasis and thrombosis. However, the functional significance of platelet P-selectin, especially its role in the platelet/leukocyte interaction, has recently begun to emerge from the insightful animal and clinical observations. Using an in vivo model of experimental thrombosis, P-selectin, expressed on activated platelets, was shown to recruit a sufficient amount of circulating leukocytes, including monocytes, to the growing thrombi (19) . This pathological event could upregulate the expression of tissue factor on the monocytes in situ and could eventually lead to significantly more deposition of fibrin within the thrombi (22) . Along this line of investigation, defective haemostasis featured by a 40% prolongation of bleeding time and a twofold increase in hemorrhage was observed in P-selectin knockout mice (7) . Blocking of P-selectin by P-selectin MoAbs could accelerate the streptokinase-induced pharmacological thrombolysis in a primate model of arterial thrombosis (20) . Leukocyte adhesion blocking MoAbs against P-selectin could also decrease the thrombus formation in a venous thrombosis model of baboons (22) . Clinically, patients with stable coronary artery disease had increased platelet reactivity characterized by P-selectin expression and circulating monocyte-platelet aggregates mediated by P-selectin (23) .
Recently, resting and activated platelets have been shown to roll on the stimulated endothelial cells in a P-selectin-dependent manner in vivo (9, 10) . Further, P-selectin, expressed on the activated platelets, has been found to have a prominent role in stabilization of platelet aggregates and in size determination of platelet aggregates (24) . These results demonstrate that P-selectin can directly mediate heterotypic aggregation of platelets on the stimulated endothelial cells and homotypic aggregation of the activated platelets.
In this study, we have shown that P-selectin affinity chromatography can precipitate one 28-kDa glycoprotein from human platelets in a Ca 2+ -dependent manner (Fig. 1A and Fig. 2 ). The isolated protein binds to P-selectin, but not to human IgG. G1 (a leukocyte adhesion blocking MoAb to P-selectin), but not PS1 (a leukocyte adhesion non-blocking MoAb to P-selectin), inhibits this binding (Figs. 1B and C) . This protein is expressed on the cell surface of platelets (Fig. 3) . And the isolated 28-kDa molecule can neutralize the binding of P-selectin to resting and activated human platelets, indicating the potentially functional importance of this molecule as a platelet ligand for P-selectin (Fig. 4) . P-selectin has been reported to bind to platelet glycoprotein Ib␣ in Ib-IX-V complex (11) and platelet PSGL-1 (12) . The interaction of P-selectin with platelet glycoprotein Ib␣ in Ib-IX-V complex is known to be independent of Ca 2+ . As the result, the reason that P-selectin affinity chromatography failed to isolate platelet glycoprotein Ib␣ in Ib-IX-V complex could be well explained by the EDTA elution of the P-selectin conjugated resins used here. However, it was quite puzzling Fig. 5 Effects of a blocking PSGL-1 MoAb on the binding of P-selectin to platelets. HL-60 cells and resting and activated platelets were incubated with human IgG or P-selectin Rg, in the absence or presence of KPL1 (a leukocyte adhesion blocking MoAb to PSGL-1), followed by an FITC-conjugated goat Ab against human IgG. The binding events were analyzed from 10 4 platelets using flow cytometry, as described above and very unexpected to us why P-selectin affinity precipitation followed by boiling the beads in the SDS sample buffer failed to detect it (Fig. 3) . Further, it was difficult to reconcile the published results of platelet PSGL-1 for P-selectin (12) with our data that P-selectin affinity chromatography and P-selectin affinity precipitation assay both failed to precipitate platelet PSGL-1 (Figs. 1-3) . We speculate that it could possibly be due to the low copy numbers of PSGL-1 on human platelets (25-to 100-fold lower expression compared to human leukocytes) (12) . In this regard, it should be pointed out that, on the basis of our current findings, we could not completely exclude the possibility of the 28-kDa molecule as a proteolytic fragment of platelet membrane glycoproteins, such as platelet glycoprotein Ib or PSGL-1.
Alternatively, it would suggest that the platelet glycoprotein Ib␣ in Ib-IX-V complex and platelet PSGL-1 may not be the physiological platelet ligands for P-selectin. In support of this suggestion, we found that KPL1 (a leukocyte adhesion blocking MoAb to PSGL-1) could inhibit the binding of P-selectin to human promyeloid HL-60 cells, but it did not inhibit the binding of P-selectin to human platelets (Fig. 5) . Notably, P-selectin and PSGL-1 knockout mice both manifest the compromised adhesion of leukocytes upon inflammatory challenges. However, P-selectin knockout mice, but not PSGL-1 knockout mice, are reportedly defective in haemostasis (8) .
It is noteworthy that P-selectin bound avidly and specifically to resting and activated human platelets fixed with 2% paraformaldehyde (Figs. 4 and 5 ). This finding is reminiscent of the previous observation that P-selectin bound to the fixed human neutrophils (16) , indicating the potential carbohydrate nature of ligand molecules on human platelets for P-selectin recognition. This result is also consistent with the identification of a ~28-kDa glycoprotein from human platelets as a P-selectin binding molecule.
In conclusion, we believe that the ~28-kDa glycoprotein on human platelets may function as a physiological ligand for P-selectin. We are currently under active progress of molecular elucidation of the primary structure of this molecule as well as evaluation of its functional importance in haemostasis and thrombosis.
